Clinical Trial

The Effect of Huel on Markers of Inflammation

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This project will assess the effect of Huel on markers of gastrointestinal inflammation of 30 generally healthy individuals. The aim is to identify any changes in the markers of inflammation status of volunteers in any of the 9 markers to be monitored. Inflammation status will be measured at the start of the study, after one week of their habitual diets and again after four weeks of consuming two ready to drink Huel products per day, one Hot \& Savoury Huel (grain-based option only) and the remainder of their calorie intake to be made up of Huel Powder (v3.1).
Trial Details
NCT Number NCT07049874
Lead Sponsor Newcastle University
Collaborators: Aelius Biotech
Conditions 4 Weeks Supplementation of Huel Ready to Eat Foods
Enrollment 30 participants
Start Date 2025-02-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-03